The cost of branded pharmaceuticals and quality and availability of generic versions are two key issues facing the U.S. marketplace.
Researchers at Stanford are exploring using traditional marketing strategies to help increase COVID-19 vaccine acceptance.
A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.
Stanford health economist Kevin Schulman examines how inefficiencies in the health care system affect the nation and individuals — including his own family.
Ethical and legal issues accompany the potential benefits of using computer vision-based ambient intelligence in health care.